Crossmark

Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis

Published Online: 2022-07-07

Published Print: 2022-08

Authors

Armstrong, April

Fahrbach, Kyle

Leonardi, Craig

Augustin, Matthias

Neupane, Binod

Kazmierska, Paulina

Betts, Marissa

Freitag, Andreas

Kiri, Sandeep

Taieb, Vanessa

Slim, Mahmoud

Gomez, Natalie Nunez

Warren, Richard B.
Funding

Funding for this research was provided by:

UCB Pharma
License Information

Text and Data Mining valid from 2022-07-07

Version of Record valid from 2022-07-07
More Information

Article History

Received: 16 May 2022

Accepted: 8 June 2022

First Online: 7 July 2022

Document is current